NovaBay Pharmaceuticals, Inc. (NBY)
1.81
+0.26
(+16.77%)
USD |
NYAM |
Dec 09, 16:00
1.73
-0.08
(-4.42%)
Pre-Market: 08:58
NovaBay Pharmaceuticals EPS Diluted (Quarterly): -0.22 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.333M |
| Revenue (Quarterly) | 0.521M |
| Total Expenses (Quarterly) | 1.854M |
| Enterprise Value | 231.06M |
| Gross Profit Margin (Quarterly) | 8.06% |
| Profit Margin (Quarterly) | -255.9% |
| Earnings Yield | 32.89% |
| Normalized Earnings Yield | 37.12 |